• Martijn A Verkade, Jelle L Epker, Mariska D Nieuwenhoff, Jan Bakker, and Erwin J O Kompanje.
• Department of Intensive Care Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
• Neurocrit Care. 2012 Feb 1;16(1):130-5.

ObjectiveTo determine the incidence of withdrawal of life-sustaining treatment in various groups of patients in a mixed intensive care unit (ICU).DesignObservational retrospective.SettingUniversity hospital mixed medical, neurological, neurosurgical and surgical ICU.PatientsAll patients admitted to the ICU between 1 November 2006, and 31 October 2007.Results1,353 Patients were admitted to our ICU between 1 November 2006, and 31 October 2007. During this period, 218 (16.1%) patients died in the ICU, 10 of which were excluded for further analysis. In 174 (83.7%) of the remaining 208 patients, life-sustaining treatment was withdrawn. Severe CNS injury was in 86 patients (49.4%) being the reason for withdrawal of treatment, followed by MODS in 67 patients (38.5%). Notably, treatment was withdrawn in almost all patients (95%) who died of CNS failure. Patients who died in the ICU were significantly older, more often admitted for medical than surgical reasons, and had higher SOFA and APACHE II scores compared with those who survived their ICU stay. Also, SOFA scores before discharge/death were significantly different from admission scores. Of the 1,135 patients who survived their ICU stay, only 51 patients (4.5%) died within 28 days after ICU discharge.ConclusionsIn 83, 7% of patients who die in the mixed ICU life-sustaining treatment is withdrawn. Severe cerebral damage was the leading reason to withdraw life-sustaining treatment.

22 keywords...

hide…